Inter-donor variability of phase I/phase II metabolism of three reference drugs in cryopreserved primary human hepatocytes in suspension and monolayer-Reference-Cited by-同舟云学术

Inter-donor variability of phase I/phase II metabolism of three reference drugs in cryopreserved primary human hepatocytes in suspension and monolayer

Published:2016-06 Issue: Volume:33 Page:71-79
ISSN:0887-2333
Container-title:Toxicology in Vitro
language:en
Short-container-title:Toxicology in Vitro

Author:

den Braver-Sewradj Shalenie P.,den Braver Michiel W.,Vermeulen Nico P.E.,Commandeur Jan N.M.,Richert Lysiane,Vos J. Chris

Funder

Innovative Medicines Initiative

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference75 articles.

1. Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defects;Adjei;Birth Defects Res. A Clin. Mol. Teratol.,2008

2. Effect of chromium and cobalt ions on phase I and phase II enzymatic activities in vitro in freshly isolated rat hepatocytes;Afolaranmi;Toxicol. In Vitro,2011

3. Cryopreservation of adult human hepatocytes obtained from resected liver biopsies;Alexandre;Cryobiology,2002

4. Can in vitro metabolism-dependent covalent binding data distinguish hepatotoxic from nonhepatotoxic drugs? An analysis using human hepatocytes and liver S-9 fraction;Bauman;Chem. Res. Toxicol.,2009

5. Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes;Blanchard;Eur. J. Pharm. Sci.,2004

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protocol to create phenotypic primary human hepatocyte cultures using the RASTRUM 3D cell model platform;STAR Protocols;2024-09

2. A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment;Biomolecules;2024-01-12

3. Control Compounds for Preclinical Drug-Induced Liver Injury Assessment: Consensus-driven systematic review by the ProEuroDILI Network;2023-11-09

4. HepG2 spheroids as a biosensor-like cell-based system for (geno)toxicity assessment;Chemosphere;2022-03

5. Leveraging interacting signaling pathways to robustly improve the quality and yield of human pluripotent stem cell-derived hepatoblasts and hepatocytes;Stem Cell Reports;2022-03